Itovebi (Inavolisib) Mechanism of Action in Treating Advanced Breast Cancer
Itovebi is a potent kinase inhibitor that has gained attention in the treatment landscape for advanced breast cancer, particularly when used in combination with other therapeutic agents like palbociclib and fulvestrant. Its primary indication lies in targeting specific breast cancer subtypes, notably endocrine-resistant, PI3KCA-mutated, HR-positive, and HER2-negative breast cancer in adult patients. This specificity is … Read more